本月全球药品研发进展取得成效的药物有56个,较上月大幅减少23个。进入注册阶段的有27个,比上月大幅减少20个。其中,8个为全球首次注册的药品,在新市场补充注册的为19个。进入注册前阶段的有14个,比上月增加1个。进入Ⅲ期临床研究阶段的有15个,比上月减少4个。 There were 56 drugs that made progress in global pharmaceutical research and development this month, a sharp decrease of 23 from the previous month. There were 27 registrations, a sharp decrease of 20 from the previous month. Of these, 8 were the first drugs registered in the world and 19 were newly registered in the new market. There were 14 in the pre-registration phase, an increase from the previous month. Into the phase Ⅲ clinical research phase of 15, a decrease of 4 from the previous month.